Evaluating Optimal Magnesium Amount in a New Intravenous Formulation for Diverse Populations | Allucent

Using PBPK to Optimize Magnesium Concentrations in an Intravenous Formulation

Using PBPK to Optimize Magnesium Concentrations in an Intravenous Formulation

A new intravenous formulation was developed and the client wanted to know if Allucent could help evaluate the proposed magnesium amount in the new formulation considering various populations of pregnant women, neonates, infants, pediatric patients, adults, and adults with renal impairments.

Download the full case study below to learn more.


DOWNLOAD RESOURCE

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Join the A-Team

Want to help small and mid-sized biotech companies change the therapeutic landscape?

Subscribe to our monthly newsletter